Worsening Mental Health in a 34-Year-Old Patient With Type 2 Diabetes After Initiation of Semaglutide (Ozempic)

IF 4.6 3区医学 Q2 ENDOCRINOLOGY & METABOLISM

Endocrine Practice Pub Date : 2025-08-29 DOI:10.1016/j.eprac.2025.05.023

引用次数: 0

查看原文本刊更多论文

1例34岁2型糖尿病患者服用西马鲁肽后精神健康状况恶化

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Endocrine Practice ENDOCRINOLOGY & METABOLISM-

CiteScore

7.60

自引率

2.40%

发文量

546

审稿时长

41 days

期刊介绍： Endocrine Practice (ISSN: 1530-891X), a peer-reviewed journal published twelve times a year, is the official journal of the American Association of Clinical Endocrinologists (AACE). The primary mission of Endocrine Practice is to enhance the health care of patients with endocrine diseases through continuing education of practicing endocrinologists.